Details for 2016167534
Up to date per 03.04.2026
Actions
Details for 2016167534
Granted/Registered
European Patent
12.10.2016 A
24.06.2020 B1
28.09.2007
US
976343 P
20.08.2008
US
90574 P
C12N 9/64 20060101AFI20160829BHEP
Owner
ALEXION PHARMACEUTICALS, INC.121 Seaport Boulevard, Boston Massachusetts 02210US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
LU, Genmin1439 El Camino Real Apt. 9 Burlingame, CA 94010US
PHILLIPS, David R.520 Harvard Road San Mateo, CA 94402US
ANDRE, Patrick287 Taylor Road South Short Hills, NJ 07078US
SINHA, Uma808 Junipero Serra Boulevard San Francisco, CA 94127US
Information about Fees